SYNOSTE Raises Funds for Smart Skeletal Deformity Correction Tools

SYNOSTE raised €5.1MM (~USD $5.9MM) to support clinical investigations and new application development as it pursues the third generation of patient-friendly bone lengthening and deformity correction devices.

The funding was provided by Lifeline Ventures and AO Foundation-backed AO Invest, and brings the total equity invested in SYNOSTE to...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us